Sebastian Wanless
Corporate Officer/Principal at TCB Newco Ltd.
Profile
Sebastian Wanless is currently working as a Senior Clinical Director at TCB Newco Ltd.
He previously worked as a Senior Medical Director at Bristol-Myers Squibb Foundation from 2003 to 2007.
Additionally, he worked as a Director-Clinical Operations at TC Biopharm (Holdings) Plc from 2020 to 2022.
Sebastian Wanless active positions
| Companies | Position | Start |
|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
Former positions of Sebastian Wanless
| Companies | Position | End |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 2022-08-31 |
| Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 2006-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private companies | 2 |
|---|---|
| Bristol-Myers Squibb Foundation | |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Stock Market
- Insiders
- Sebastian Wanless